Activated autologous T cell killing of CD 20+ B cell lymphoma in the Dog.

For further information on these trial contact: Heather Wilson, DVM, DACVIM (Oncology) 979-845-235 animalcancer@cvm.tamu.edu

Study details:

Species: Dogs

Tumor: Lymphoma

Purpose of Study: Any dog weighing over 35 lbs that has been diagnosed with B cell Lymphoma and is being treated with prednisone alone is eligible for this study.